RxDoctor Payments Data

Isabel Arroyo Gomez

Endocrinology, Diabetes & Metabolism · Cayey, PRNPI 1770136871

Payments from drug & device makers

$4,996in general payments, 2019–2025

Across 166 payments — averaging $30.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$571
  • Amgen$550
  • Dexcom, Inc.$412
  • AstraZeneca$380
  • Novo Nordisk$347
  • Eli Lilly Export S.A. Puerto Rico Branch$346
  • plus $2K from 17 others

What the payments were for

  • Travel & lodging$311%
  • Food & beverage$4,96499%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,996 in reported general payments places this provider in the 50th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.

See all endocrinology, diabetes & metabolism providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide18$21,225
TrulicityDulaglutide15$14,623
SynthroidLevothyroxine Sodium129$6,173
HumalogInsulin Lispro14$2,032
Desmopressin Acetate11$646
Hydrocortisone28$404
Rosuvastatin Calcium45$325
Nifedipine ErNifedipine11$293
Atorvastatin Calcium34$279
Ezetimibe30$235
Losartan Potassium26$180
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide14$117
Lisinopril19$105
Doxazosin Mesylate11$102
Metformin Hcl22$88

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$237$37,88147 claims
AbbVieSynthroid$237$6,173129 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.

Other endocrinology, diabetes & metabolism in Cayey

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →